Journal
TRENDS IN BIOTECHNOLOGY
Volume 34, Issue 6, Pages 470-482Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tibtech.2016.03.009
Keywords
-
Categories
Funding
- European Commission [602694, 606624]
- People Programme (Marie Curie Actions) under REA grant [622294]
- BBSRC [BB/I02643X/1] Funding Source: UKRI
- Biotechnology and Biological Sciences Research Council [BB/I02643X/1] Funding Source: researchfish
Ask authors/readers for more resources
Current state-of-the-art biomedical implants and tissue engineering methods promise technologies to improve or even restore the function of diseased organs. However, one of the biggest challenges to clinical success is the lack of functional integration. A series of cellular and molecular events following biomaterial implantation poses an important bottleneck for developing breakthrough solutions. With inflammation increasingly recognized as a crucial component influencing regeneration, immunomodulation or immuno-engineering has emerged as a potential solution to overcome this key challenge in regenerative medicine. We postulate possibilities to utilize biomaterial physicochemical modifications to modulate the host inflammatory response and develop strategies for effective biomaterial integration. Biomaterial-based immunomodulation strategies can significantly ameliorate the outcomes of medical implants and tissue engineering therapies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available